Vladimir Vexler, Chief Scientific Officer at Coherus BioSciences, Inc. (CHRS), sold 114,240 shares at $16.25 ($1.9M) on 2021-03-09, disclosed to the SEC on 2021-03-11.
Open-market sale of $1.9M CHRS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.